XML 58 R29.htm IDEA: XBRL DOCUMENT
v3.23.4

Commitments and Contingencies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Commitments and Contingencies |
Schedule of milestone payments the Company shall pay to Licensor | ​
​ | ​ | ​ | ​
Milestone Event |  | Amount
Enrollment of first patient in a phase II clinical trial of a therapeutic product or process | ​ | $ | 100,000
Enrollment of first patient in a phase III clinical trial of a therapeutic product or process | ​ | $ | 200,000
First commercial sale of a therapeutic product or process | ​ | $ | 1,000,000
Filing of an application for regulatory approval of a clinical diagnostic product or process | ​ | $ | 100,000
First regulatory approval of a clinical diagnostic product or process | ​ | $ | 150,000

X
- Definition Tabular disclosure of milestone payments the Company shall pay to Licensor. + References No definition available. + Details
Name: | rnaz_ScheduleOfMilestonePaymentsCompanyShallPayToLicensorTableTextBlock
Namespace Prefix: | rnaz_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration